Table 3.
Adjusted hazard ratios for all-cause and cancer-specific incidence rates estimated for greenhouse gas emissions and land use contributions from diet, modelled as quartiles
| Events (%) |
Greenhouse gas emissions: adjusted hazard ratios*(95% CI) |
Land use contributions: adjusted hazard ratios*(95% CI) |
|||||
|---|---|---|---|---|---|---|---|
| Second quartile† | Third quartile† | Fourth quartile† | Second quartile† | Third quartile† | Fourth quartile† | ||
| All-cause cancer | 58 925 (12·9%) | 1·03 (1·01–1·06) | 1·08 (1·06–1·11) | 1·11 (1·09– 1·14) | 1·04 (1·01–1·06) | 1·10 (1·07– 1·12) | 1·13 (1·10–1·15) |
| Brain and CNS | 827 (0·2%) | 1·14 (0·93–1·39) | 1·18 (0·97–1·44) | 0·93 (0·76–1·15) | 1·01 (0·83–1·24) | 1·30 (1·06–1·56) | 1·09 (0·89–1·33) |
| Bladder, renal, pelvis, ureter, and other urinary organs | 1584 (0·4%) | 1·17 (1·01–1·36) | 1·29 (1·12–1·50) | 1·47 (1·28–1·70) | 1·20 (1·03–1·40) | 1·45 (1·25–1·68) | 1·52 (1·31–1·76) |
| Breast‡ | 13 283 (3·3%) | 1·05 (1·01–1·10) | 1·15 (1·10–1·21) | 1·21 (1·15–1·27) | 1·07 (1·02–1·12) | 1·14 (1·09–1·20) | 1·23 (1·17–1·29) |
| Cervical‡ | 350 (0·1%) | 0·88 (0·68–1·14) | 0·71 (0·53–0·95) | 0·66 (0·48–0·91) | 0·83 (0·64–1·09) | 0·72 (0·54–0·97) | 0·65 (0·47–0·90) |
| Colorectum | 6141 (1·5%) | 1·01 (0·94–1·09) | 1·10 (1·02–1·18) | 1·05 (0·98–1·13) | 1·03 (0·96–1·11) | 1·13 (1·05–1·22) | 1·12 (1·04–1·20) |
| Endometrium‡ | 1925 (0·7%) | 0·94 (0·84–1·06) | 0·90 (0·80 1·02) | 0·90 (0·79–1·03) | 0·85 (0·76–0·96) | 0·90 (0·80–1·02) | 0·82 (0·72–0·94) |
| Oesophagus | 468 (0·1%) | 1·17 (0·85–1·59) | 1·52 (1·14–2·04) | 2·06 (1·55–2·72) | 1·12 (0·82–1·52) | 1·59 (1·20–2·12) | 1·93 (1·46–2·55) |
| Gallbladder and biliary tract | 335 (0·1%) | 0·98 (0·73–1·34) | 0·92 (0·67–1·25) | 0·96 (0·71–1·30) | 1·02 (0·75–1·39) | 1·13 (0·84–1·53) | 0·89 (0·64–1·23) |
| Kidney | 1003 (0·3%) | 1·14 (0·95–1·39) | 1·18 (0·99–1·43) | 1·43 (1·20–1·72) | 1·07 (0·88–1·29) | 1·26 (1·04–1·51) | 1·46 (1·22–1·76) |
| Larynx | 295 (0·1%) | 1·07 (0·73–1·58) | 1·51 (1·05–2·16) | 1·70 (1·20–2·41) | 1·19 (0·80–1·78) | 1·47 (1·01–2·15) | 2·17 (1·52–3·10) |
| Liver | 439 (0·1%) | 0·94 (0·70–1·25) | 1·11 (0·84–1·46) | 1·27 (0·97–1·66) | 1·42 (1·06–1·90) | 1·26 (0·94–1·70) | 1·61 (1·21–2·14) |
| Lung | 3777 (1·0%) | 1·03 (0·93–1·13) | 1·12 (1·02– 1·23) | 1·15 (1·05– 1·27) | 1·11 (1·01–1·23) | 1·19 (1·08–1·31) | 1·23 (1·11–1·35) |
| Lymph nodes | 1397 (0·4%) | 0·98 (0·84–1·14) | 1·00 (0·86–1·16) | 1·03 (0·89–1·20) | 0·95 (0·82–1·10) | 0·98 (0·84–1·13) | 0·94 (0·81–1·10) |
| Myeloma | 1833 (0·5%) | 0·96 (0·84–1·10) | 1·01 (0·88–1·15) | 1·14 (1·00–1·30) | 1·01 (0·88–1·16) | 1·07 (0·94–1·23) | 1·17 (1·03–1·34) |
| Ovary‡ | 1415 (0·5%) | 1·04 (0·90–1·19) | 1·08 (0·94–1·24) | 0·93 (0·79–1·09) | 1·03 (0·90–1·18) | 1·00 (0·86–1·15) | 0·85 (0·72–1·00) |
| Pancreas | 1289 (0·3%) | 0·96 (0·82–1·14) | 1·14 (0·98–1·34) | 1·17 (0·99–1·37) | 1·08 (0·92–1·27) | 1·14 (0·97–1·34) | 1·25 (1·07–1·47) |
| Prostate§ | 6902 (6·0%) | 1·04 (0·96–1·13) | 1·02 (0·94–1·11) | 1·05 (0·97–1·13) | 1·16 (1·07–1·27) | 1·15 (1·05–1·24) | 1·17 (1·08–1·27) |
| Skin melanoma | 4567 (1·2%) | 1·11 (1·02–1·21) | 1·16 (1·07–1·26) | 1·13 (1·04–1·23) | 1·10 (1·01–1·20) | 1·13 (1·04–1·23) | 1·10 (1·01–1·20) |
| Stomach | 979 (0·2%) | 1·02 (0·84–1·24) | 1·21 (1·01–1·45) | 1·27 (1·05–1·52) | 1·16 (0·95–1·41) | 1·33 (1·10–1·61) | 1·52 (1·26–1·83) |
| Thyroid | 757 (0·2%) | 1·16 (0·93–1·44) | 1·35 (1·09–1·66) | 1·42 (1·15–1·75) | 1·17 (0·94–1·47) | 1·48 (1·20–1·83) | 1·64 (1·33–2·02) |
*
Models adjusted for age at recruitment, marital status, education, physical activity, smoking status, and body-mass index.
†
The first quartile is the reference value.
‡
Women only.
§
Men only.